VHT.AX - Volpara Health Technologies Limited
| Previous close | 0.7300 |
| Open | 0.7100 |
| Bid | 0.7050 x 1161000 |
| Ask | 0.7250 x 1753300 |
| Day's range | 0.7050 - 0.7350 |
| 52-week range | 0.4000 - 0.8700 |
| Volume | |
| Avg. volume | 141,668 |
| Market cap | 179.322M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0300 |
| Earnings date | 25 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.20 |
PR NewswireVolpara Health Joins CancerX
Volpara Health Technologies Ltd. (ASX: VHT) proudly announces its founding membership in CancerX, a public-private partnership aimed at revolutionizing cancer innovation in the United States. As a global leader in cancer detection software, Volpara joins other leaders in advancing patient care, communication, and policy in the fight against this devastating disease.
Simply Wall St.Volpara Health Technologies Limited (ASX:VHT) Annual Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Volpara Health Technologies Limited ( ASX:VHT ) last week reported its latest yearly results, which makes it a good...
PR NewswireArtificial Intelligence from ScreenPoint Medical and Volpara Health Demonstrates Ability to Predict Long-Term Breast Cancer Risk
Researchers from the Mayo Clinic (Rochester, MN) and University of California, San Francisco confirmed that pairing artificial intelligence (AI) imaging and volumetric breast density algorithms can assist in predicting long-term risk of breast cancer, in particular invasive disease. The study, "Impact of Artificial Intelligence System and Volumetric Density on Risk Prediction of Interval, Screen-Detected, and Advanced Breast Cancer," was recently published in the Journal of Clinical Oncology.
- Simply Wall St.
Here's Why We're Not Too Worried About Volpara Health Technologies' (ASX:VHT) Cash Burn Situation
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
- Simply Wall St.
Volpara Health Technologies Limited (ASX:VHT): When Will It Breakeven?
Volpara Health Technologies Limited ( ASX:VHT ) is possibly approaching a major achievement in its business, so we...
- PR Newswire
Volpara highlights cancer risk assessment, breast density assessment and mammography quality software at SBI 2023
Volpara Health Technologies Ltd. (ASX: VHT), a global leader in software for the early detection of cancer, is attending the 2023 Society of Breast Imaging annual symposium, May 4-7 in Maryland. The company will be showcasing how breast care professionals can use its software to quantify cancer risk and provide personalized care planning as well as help improve efficiency, accuracy and quality of the whole mammography process.
- PR Newswire
Volpara announces expanded sponsorship of DenseBreast-Info.org at SBI 2023
Volpara Health Technologies Ltd. (ASX: VHT), a global leader in software for the early detection of cancer, is announcing an expanded sponsorship of DenseBreast-info.org (DBI) at this year's Society of Breast Imaging (SBI) annual symposium in Maryland. Volpara will donate 5% of the profits from all sales of its Volpara Scorecard™ breast density assessment software to DBI for the next twelve months.
- Simply Wall St.
Getting In Cheap On Volpara Health Technologies Limited (ASX:VHT) Is Unlikely
Volpara Health Technologies Limited's ( ASX:VHT ) price-to-sales (or "P/S") ratio of 6.9x might make it look like a...
- Simply Wall St.
Volpara Health Technologies (ASX:VHT) investors are sitting on a loss of 21% if they invested three years ago
Volpara Health Technologies Limited ( ASX:VHT ) shareholders will doubtless be very grateful to see the share price up...
- PR Newswire
Volpara to showcase comprehensive product offerings at NCoBC 2023
Volpara Health Technologies Ltd. (ASX: VHT), a global leader in software for the early detection of cancer, is attending this year's National Consortium of Breast Centers (NCoBC) conference in Las Vegas to showcase its software advancements that are powering today's progressive breast centers.
PR NewswireFDA Breast Density Reporting Rule is a Critical Step for Women says Volpara Health, the Leader in AI-assisted Breast Density Measurement
Volpara Health Technologies ("Volpara," "the Group," or "the Company"; ASX:VHT), a global leader in software for the early detection of breast cancer, today announced that a new US federal regulation was finalized by the US Food and Drug Administration (FDA) requiring mammography facilities across the country to inform patients whether their breasts are composed of dense tissue. The regulation standardizes language and expands the number of states with density disclosure laws nationwide.
- PR Newswire
New Research at ECR 2023 Uses Volpara AI to Personalize, Optimize Breast Cancer Detection
Volpara Health Technologies Ltd. (ASX: VHT), a global leader in software for the early detection of cancer, was highlighted in research presented at the 2023 European Congress of Radiology (ECR). The new studies demonstrate the important role artificial intelligence plays in objective breast density assessment, cancer risk assessment, and mammography quality evaluation to personalize and optimize breast cancer detection.
- Simply Wall St.
Volpara Health Technologies Limited's (ASX:VHT) largest shareholders are individual investors with 57% ownership, insiders own 25%
Every investor in Volpara Health Technologies Limited ( ASX:VHT ) should be aware of the most powerful shareholder...
- Simply Wall St.
Great news for Volpara Health Technologies Limited (ASX:VHT): Insiders acquired stock in large numbers last year
When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...
- Simply Wall St.
Volpara Health Technologies (ASX:VHT) Is In A Good Position To Deliver On Growth Plans
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- PR Newswire
Volpara Health software used in largest image quality evaluation to date
At the 2022 Radiological Society of North America (RSNA) Annual Meeting, Peter R. Eby, MD, of Virginia Mason Medical Center presented the results of the largest mammographic image quality evaluation to date, titled "Reduction in technical repeat and recall rate after implementation of artificial intelligence driven quality improvement software."
- PR Newswire
Personalized breast care advancements from Volpara Health empower providers, patients, and partners at RSNA 2022
Volpara Health Technologies Ltd. (ASX: VHT), a global leader in software for the early detection of cancer, will showcase advancements in personalized breast care at the Annual Radiological Society of North America (RSNA) meeting, November 27 to December 1, 2022 (South Hall, #2772).
- Simply Wall St.
Volpara Health Technologies First Half 2023 Earnings: NZ$0.02 loss per share (vs NZ$0.034 loss in 1H 2022)
Volpara Health Technologies ( ASX:VHT ) First Half 2023 Results Key Financial Results Revenue: NZ$16.9m (up 37% from 1H...
- Simply Wall St.
When Will Volpara Health Technologies Limited (ASX:VHT) Turn A Profit?
We feel now is a pretty good time to analyse Volpara Health Technologies Limited's ( ASX:VHT ) business as it appears...
- PR Newswire
Volpara Health proudly attains B Corp Certification
Volpara Health (ASX: VHT), a global leader in software for the early detection of cancer, today announced that it is a Certified B Corporation, or B Corp.
- Simply Wall St.
The past three years for Volpara Health Technologies (ASX:VHT) investors has not been profitable
The truth is that if you invest for long enough, you're going to end up with some losing stocks. Long term Volpara...
- PR Newswire
Volpara Health launches Professional Services to accelerate success for high-risk cancer programs
Volpara Health (ASX: VHT), a global leader in software for the early detection of breast cancer, today announced the launch of its new comprehensive Professional Services offering to help its Risk Pathways customers maximize the value of their high-risk cancer assessment programs.
- Simply Wall St.
Volpara Health Technologies Limited's (ASX:VHT) Intrinsic Value Is Potentially 82% Above Its Share Price
How far off is Volpara Health Technologies Limited ( ASX:VHT ) from its intrinsic value? Using the most recent...
- Simply Wall St.
Is It Time To Consider Buying Volpara Health Technologies Limited (ASX:VHT)?
Volpara Health Technologies Limited ( ASX:VHT ), might not be a large cap stock, but it led the ASX gainers with a...
PR NewswireVolpara Health collaborates with Microsoft to accelerate the research and development of software that uses mammograms to identify potential cardiovascular issues
Volpara Health Technologies ("Volpara," "the Group," or "the Company"; ASX: VHT), a global health technology software leader providing an integrated platform for personalized breast care, today announced a new research and development agreement with Microsoft to accelerate the creation of a solution that detects and quantifies breast arterial calcifications (BAC).